Dr. Navaz P Karanjia MD

Media Releases

Get to know Neurologist & Neurocritical Care Specialist Dr. Navaz P. Karanjia, who serves the population of California. Dr. Karanjia graduated from Stanford University, School of Medicine with her Medical Degree, where she also completed her internal medicine internship. She then completed her Neurology residency with the UCLA Medical Center. Wanting to further her training she then completed her Neurocritical Care Fellowship with the Johns Hopkins University. Dr. Karanjia is dual certified in Neurocritical Care and Neurology with the American Board of Psychiatry and Neurology. She is also certified in neurocritical care from the United Council for Neurologic Subspecialties. To stay up to date in her field, she remains a professional member of the American Heart Association/American Stroke Association, the Society of Critical Care Medicine, the Neurocritical Care Society, and the American Academy of Neurology. She is medical director of UC San Diego Health’s Neurocritical Care Program and Neuro-Intensive Care Unit (ICU), which she also founded. The Neuro-ICU team provides around-the-clock expert care, seven days a week, to critically ill patients who may have severe brain injury, stroke or brain tumors, or may be recovering from a neurosurgical procedure. Dr. Karanjia is an associate professor in the Departments of Neurosciences and Anesthesiology at UC San Diego School of Medicine. Her research interests include early detection of neurologic deterioration and evaluating methods for monitoring cerebral blood flow and intracranial pressure. She has published several book chapters and articles in leading journals, including Neurocritical Care and Archives of Neurology. Neurology is a branch of medicine dealing with disorders of the nervous system. Neurology deals with the diagnosis and treatment of all categories of conditions and disease involving the central and peripheral nervous systems (and their subdivisions, the autonomic and somatic nervous systems), including their coverings, blood vessels, and all effector tissue, such as muscle. Neurological practice relies heavily on the field of neuroscience, which is the scientific study of the nervous system. Neurologists may also be involved in clinical research, clinical trials, and basic or translational research.

Recommended Articles

• What Are the Treatments for Stroke?

  Emergency treatment for stroke is dependent on the type of stroke you're suffering from. Whether it is an ischemic stroke that blocks an artery, or a hemorrhagic stroke that is caused by bleeding of blood vessels around the brain, acting fast is important since every minute counts.Ischemic Stroke:...

• Multiple Sclerosis: Coping with Grief

  Just hearing the word grief can evoke feelings of sadness, but is grief just “being sad”? Or is it something more complex? The word itself seems to have a stronger meaning than “sad.”According to the Mayo Clinic, for many people, including those diagnosed with a chronic illness, grief is a...

• Anti-Inflammatory Drugs for Multiple Sclerosis

  Multiple sclerosis is a disease that affects the brain and spinal cord. It involves an immune-mediated process, which results in an abnormal response. Such abnormal response leads to the damage of the central nervous system tissue and the immune system, which attacks the myelin causing...

• Medical History May Be Able to Predict Parkinson's Disease

  A study led by Susan Searles Nielsen, PhD, MS, assistant professor of neurology at the Washington University located in St. Louis, Missouri, looked into a new method that utilizes past medical records in order to predict whether or not a patient will develop Parkinson’s disease.  This approach...

• Nortis Inc. Receives $688K to Revolutionize Multiple Sclerosis Treatment

  One Seattle-based technology recently revealed new clinical technology that could completely change the way multiple sclerosis is treated. The firm received $668,000 to develop an in-vitro blood barrier that mimics the human blood-brain barrier, an innovation that would make MS drug development more...

• Can Schizophrenia Be Treated?

  Schizophrenia is a severe disorder of the mind that requires lifelong treatment. An individual suffering from this disorder is not able to identify the difference between what actually exists and what is in their mind. This disorder has an adverse effect on the way an individual thinks and reacts to...